Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Daewon Pharmaceutical Co Ltd
KRX:003220
Daewon Pharmaceutical Co Ltd
KRX:003220
Price:
7 890
KRW
Market Closed
Market Cap:
₩177B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Daewon Pharmaceutical Co Ltd
KRX:003220
|
KR |
|
S
|
SMG Swiss Marketplace Group Holding AG
SIX:SMG
|
CH |
|
I
|
Inaba Denki Sangyo Co Ltd
OTC:IBADF
|
JP |
Wall St Price Targets
Price Forecast
Based on 5 analysts
Based on 5 analysts
+94% Upside
from
₩7 890
today
Daewon Pharmaceutical Co Ltd (003220)’s 12-month stock price forecast through October 2027 has a consensus target of ₩15 300, implying 94% upside. The forecast is based on price targets from 5 Wall Street analysts.
Analyst Rating
No ratings yet
No ratings yet
Daewon Pharmaceutical Co Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Daewon Pharmaceutical Co Ltd's stock price target?
Price Target
15 300
KRW
15 300
KRW
According to Wall Street analysts, the average 1-year price target for Daewon Pharmaceutical Co Ltd is 15 300 KRW with a low forecast of 13 130 KRW and a high forecast of 16 800 KRW.
What is the Revenue forecast for Daewon Pharmaceutical Co Ltd?
Projected CAGR
3%
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 3%.
What is the Gross Profit forecast for Daewon Pharmaceutical Co Ltd?
Projected CAGR
7%
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 1 year is 7%.
What is the Operating Income forecast for Daewon Pharmaceutical Co Ltd?
Projected CAGR
94%
94%
Over the last 13 years, the compound annual growth rate for Operating Income has been -10%. The projected CAGR for the next 3 years is 94%.
What is the Pre-Tax Income forecast for Daewon Pharmaceutical Co Ltd?
Projected CAGR
128%
128%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -12%. The projected CAGR for the next 3 years is 128%.